Emily Bergsland, MD

Emily  Bergsland, MD

Specialty: Medical Oncology

UCSF Helen Diller Family Comprehensive Cancer Center

Multidisciplinary NET treatment program

Mission Hall, 550 16th Street Box 3211
San Francisco, California

Patient scheduling: (415) 353-9888

Online bio
90% of practice is NET patients
20 years’ experience treating NETs
52 published NET-related research papers

Emily Bergsland, MD is actively involved in neuroendocrine cancer research.

Research interests:

NET clinical trials, outcomes in NET patients, studies of NET biology

Subspecialty areas:

  • Lung NETs
  • GI NETs
  • Pancreatic NETs
  • Pheochromocytoma/Paraganglioma
  • Liver metastasis
  • Neuroendocrine carcinoma (poorly differentiated)

NET-related professional association memberships:

  • North American Neuroendocrine Tumor Society (NANETS)
  • European Neuroendocrine Tumor Society (ENETS)
  • American Association of Cancer Research (AACR)
  • NCCN NET Guidelines Panel Member

Leadership role(s):

  • North American Neuroendocrine Tumor Society (NANETS)
  • NCCN Guidelines Panel Member

NETRF-funded research

Emily Bergsland, MD,  received a 2018 NETRF Investigator Grant for the study “New strategies to improve drug development for carcinoid tumors.”


Presentations by Emily Bergsland, MD